https://www.selleckchem.com/pr....oducts/heptadecanoic
Studies concerning the impact of the AT(N) framework on diagnostic capability in the dementia population are lacking. We aimed to explore the diagnostic application of CSF AT(N) framework in clinical routines of Alzheimer's disease (AD) as well as differential diagnosis of other cognitive diseases in the Chinese Han population. A total of 137 patients with cognitive disorders received CSF tests of Aβ , t-tau and p-tau . Their CSF biomarker results were categorized and interpreted by the AT(N) framework. Neurologists provided
Like
Comment
Share
